BSE filing, NSE: LEADFIN. Summary written from the filing by ALFA Finder's alert engine.
Lead Financial Services Ltd: key numbers
- Share price
- ₹14.75
- Market cap
- ₹4.87 Cr
- Revenue (annual)
- ₹0.58 Cr
- Net profit (annual)
- ₹0.10 Cr
- P/E (TTM)
- 59.9×Sector 19.7×
- Promoter holding
- 28.23%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lead Financial Services Ltd
All →Lead Financial Services Board Meeting Date
Lead Financial Services scheduled its Board of Directors meeting for 02 November 2026 to consider unaudited financial results for Q1 FY27. The trading window will remain closed for insiders until 48 hours after results declaration.
Lead Financial Services Management Change
Lead Financial Services Limited re-appointed Mr. Sudesh Gupta as an Executive Director of the company effective September 30, 2026.
Lead Financial Services Annual General Meeting
Lead Financial Services Ltd held its 33rd Annual General Meeting on 30th September 2026. The meeting addressed financial statements, director appointments, and remuneration approvals.
Lead Financial Services Other Announcement
Lead Financial Services Ltd notified shareholders of the weblink to access the Integrated Annual Report for FY 2025-26.
Lead Financial Services Annual General Meeting
Lead Financial Services Ltd scheduled its 33rd AGM on September 30, 2026, via video conferencing. Remote e-voting is available from September 27 to 29, 2026.
Lead Financial Services Price Movement Clarification
Lead Financial Services clarified that recent share price volatility is market-driven. The company confirmed it has disclosed all material information required under SEBI Regulation 30.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.